drugset / Trial / NCT02843984
Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications
RandomizedParallel-groupOpen-labelPrevention
Summary
Objective: To evaluate the influence of vaginal Lactoferrin administration on amniotic fluid concentration of 47 cytokines, chemokines and growth factors.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lactoferrin | Protein / enzyme biologic | 300 mg | Other |